Tatva Chintan Pharma Chem Ltd. is currently held by 4 active mutual funds (excluding ETFs and Index funds) with a total exposure of ₹85.44 Cr. This month 1 fund entered and 1 fund exited. ICICI Prudential MNC Fund - Direct Plan - Growth Option has the highest allocation at 0.51%, followed by Nippon India ELSS Tax Saver Fund - Direct Plan Growth Plan - Growth Option at 0.46%. ↓ Scroll down for full fund list and monthly changes.
| Category | Funds | Avg Weight | Distribution |
|---|---|---|---|
| Equity | 3 | 0.32% | |
| ELSS | 1 | 0.46% |
| Fund ↕ | Category ↕ | Weight ↕ | Value ↕ | Change ↕ |
|---|---|---|---|---|
| ICICI Prudential MNC Fund - Direct Plan - Growth Option ICICI Prudential Mutual Fund |
Equity | 0.51% | ₹8.80 Cr | NEW |
| Nippon India ELSS Tax Saver Fund - Direct Plan Growth Plan - Growth Option Nippon India Mutual Fund |
ELSS | 0.46% | ₹67.74 Cr | +0.04% |
| WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth WhiteOak Capital Mutual Fund |
Equity | 0.24% | ₹1.47 Cr | +0.03% |
| ICICI Prudential Commodities Fund - Direct Plan - Growth Option ICICI Prudential Mutual Fund |
Equity | 0.20% | ₹7.44 Cr | +0.05% |